-- 根據澳洲證券交易所週二提交的文件顯示，澳洲臨床實驗室（ASX：ACL）否認了米歇爾·拉布-伊万諾夫（Michelle Raab-Ivanov）在維多利亞州最高法院提起的代表訴訟中的指控，併計劃「全力」應訴。 文件稱，訴訟代表的是2022年7月15日之前曾是該公司和/或其子公司Medlab Pathology的客戶，且其個人資訊在2022年2月Medlab Pathology遭受網路攻擊後受到影響的個人。 根據文件，該訴訟旨在根據涉嫌違反澳洲消費者法的行為，為受影響的個人尋求損害賠償。
Related Articles
Asia
Fuen Jumps 99% on Start of Shenzhen Trading Debut
Hangzhou Fuen (SHE:001312) opened 98.6% higher in its trading debut on the Shenzhen Stock Exchange.The Chinese textile product manufacturer's shares opened at 36.51 yuan apiece, nearly double from its initial public offering price of 18.38 yuan per share.
$SHE:001312
Asia
Wanhua Chemical Group 2025 Profit Down 4%; Share Fall 4%
Wanhua Chemical Group (SHA:600309) posted 2025 attributable net profit of 12.6 billion yuan, down 3.9% from 13.0 billion yuan the previous year.Earnings per share slipped to 3.99 yuan from 4.15 yuan, according to a filing with the Shanghai bourse.Analysts polled by Visible Alpha were expecting EPS of 3.85 yuan.Operating revenue rose 12% year over year to 203.2 billion yuan from 182.1 billion yuan.Analysts polled by Visible Alpha were expecting revenue of 200.0 billion yuan.Shares of the chemical company were down 4% in recent trade.
$SHA:600309
Asia
Hong Kong Introduces Framework for Secondary Trading of Tokenized Products
Hong Kong's Securities and Futures Commission rolled out a new regulatory framework to enable secondary trading of tokenized investment products, according to a press release on Monday.The initiative will initially allow trading of tokenized SFC-authorized open-ended funds on licensed virtual asset trading platforms, with the regulator also open to considering over-the-counter arrangements on a case-by-case basis.The framework introduces safeguards covering pricing, liquidity, disclosure, and orderly trading, drawing on exchange-traded fund mechanisms and existing virtual asset platform infrastructure, the regulator said.It also paves the way for potential 24/7 trading supported by regulated stablecoins and tokenised deposits.The initial rollout will focus on tokenised money market funds, with the regulator set to review operations before expanding the scope.
$^HSI